Figure 3
Figure 3. Skeletal muscle myosin promotes thrombin generation when 0.1 pM or 0.5 pM TF is added to pooled normal plasma both in the absence and the presence of 4 µM phospholipid vesicles. CTI (final, 50 µg/mL) was added to freshly thawed pooled normal human plasma (George King Bio Medical Inc., Overland Park, KS). Once-thawed pooled plasma (30 μL) was incubated with various indicated concentrations of myosin for 10 minutes at 37°C. Then, to initiate thrombin generation in the absence (A,C) or presence (B,D) of phospholipid vesicles (4 µM final) (PCPS, 80%/20% wt/wt), fluorogenic thrombin substrate solution (I-1140) with TF at either 0.1 pM (A,B) or 0.5 pM (C,D) (final concentration, as indicated) and CaCl2 (11 mM final) was added.

Skeletal muscle myosin promotes thrombin generation when 0.1 pM or 0.5 pM TF is added to pooled normal plasma both in the absence and the presence of 4 µM phospholipid vesicles. CTI (final, 50 µg/mL) was added to freshly thawed pooled normal human plasma (George King Bio Medical Inc., Overland Park, KS). Once-thawed pooled plasma (30 μL) was incubated with various indicated concentrations of myosin for 10 minutes at 37°C. Then, to initiate thrombin generation in the absence (A,C) or presence (B,D) of phospholipid vesicles (4 µM final) (PCPS, 80%/20% wt/wt), fluorogenic thrombin substrate solution (I-1140) with TF at either 0.1 pM (A,B) or 0.5 pM (C,D) (final concentration, as indicated) and CaCl2 (11 mM final) was added.

Close Modal

or Create an Account

Close Modal
Close Modal